ATE378350T1 - Hiv-peptide aus tat-, rev- und wef-konservierten regionen und deren anwendung z.b. als impfstoffkomponenten - Google Patents

Hiv-peptide aus tat-, rev- und wef-konservierten regionen und deren anwendung z.b. als impfstoffkomponenten

Info

Publication number
ATE378350T1
ATE378350T1 AT01965768T AT01965768T ATE378350T1 AT E378350 T1 ATE378350 T1 AT E378350T1 AT 01965768 T AT01965768 T AT 01965768T AT 01965768 T AT01965768 T AT 01965768T AT E378350 T1 ATE378350 T1 AT E378350T1
Authority
AT
Austria
Prior art keywords
wef
tat
rev
application
vaccine components
Prior art date
Application number
AT01965768T
Other languages
English (en)
Inventor
Birger Soerensen
Original Assignee
Bionor Immuno As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bionor Immuno As filed Critical Bionor Immuno As
Application granted granted Critical
Publication of ATE378350T1 publication Critical patent/ATE378350T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16311—Human Immunodeficiency Virus, HIV concerning HIV regulatory proteins
    • C12N2740/16322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/974—Aids related test
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/975—Kit
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/82—Proteins from microorganisms
    • Y10S530/826—Viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • AIDS & HIV (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
AT01965768T 2000-09-04 2001-09-03 Hiv-peptide aus tat-, rev- und wef-konservierten regionen und deren anwendung z.b. als impfstoffkomponenten ATE378350T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NO20004412A NO314587B1 (no) 2000-09-04 2000-09-04 HIV regulatoriske- og hjelpepeptider, antigener, vaksinepreparater, immunoassay testsett og en metode for påvisning av antistoffer fremkaltav HIV

Publications (1)

Publication Number Publication Date
ATE378350T1 true ATE378350T1 (de) 2007-11-15

Family

ID=19911532

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01965768T ATE378350T1 (de) 2000-09-04 2001-09-03 Hiv-peptide aus tat-, rev- und wef-konservierten regionen und deren anwendung z.b. als impfstoffkomponenten

Country Status (18)

Country Link
US (1) US7097971B2 (de)
EP (1) EP1322666B1 (de)
JP (1) JP2004508382A (de)
CN (2) CN1458936A (de)
AR (1) AR033997A1 (de)
AT (1) ATE378350T1 (de)
AU (2) AU2001286336B2 (de)
BR (1) BR0114046A (de)
CA (1) CA2421199A1 (de)
DE (1) DE60131432T2 (de)
EA (1) EA006210B1 (de)
ES (1) ES2296793T3 (de)
HU (1) HUP0303132A3 (de)
NO (1) NO314587B1 (de)
NZ (2) NZ535908A (de)
SK (1) SK287913B6 (de)
WO (1) WO2002020555A2 (de)
ZA (1) ZA200301742B (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL150961A0 (en) 2000-02-04 2003-02-12 Univ Duke Human immunodeficiency virus vaccine
UA97800C2 (uk) 2006-03-10 2012-03-26 Пептселл Лімітед Пептидні послідовності і композиції
JP4931483B2 (ja) * 2006-06-14 2012-05-16 ルネサスエレクトロニクス株式会社 半導体不良解析装置、不良解析方法、及び不良解析プログラム
EP2550362B1 (de) 2010-03-25 2017-01-04 Oregon Health&Science University Cmv-glycoproteine und rekombinante vektoren
CN102210874A (zh) * 2011-05-17 2011-10-12 浙江大学 一种hiv重组亚型dna疫苗的制备方法
CA2832109C (en) 2011-06-10 2021-07-06 Oregon Health & Science University Cmv glycoproteins and recombinant vectors
AU2012216792A1 (en) 2011-09-12 2013-03-28 International Aids Vaccine Initiative Immunoselection of recombinant vesicular stomatitis virus expressing HIV-1 proteins by broadly neutralizing antibodies
US9402894B2 (en) 2011-10-27 2016-08-02 International Aids Vaccine Initiative Viral particles derived from an enveloped virus
WO2013182661A1 (en) * 2012-06-06 2013-12-12 Bionor Immuno As Peptides derived from viral proteins for use as immunogens and dosage reactants
EP2679596B1 (de) 2012-06-27 2017-04-12 International Aids Vaccine Initiative HIV-1 Env-proteinvariante
NZ708836A (en) * 2012-12-06 2020-07-31 Pin Pharma Inc Treatment of inflammation, autoimmune, and neurodegenerative disorders with immunosuppressive tat derivative polypeptides
US20150065381A1 (en) 2013-09-05 2015-03-05 International Aids Vaccine Initiative Methods of identifying novel hiv-1 immunogens
EP2873423B1 (de) 2013-10-07 2017-05-31 International Aids Vaccine Initiative Lösliche hiv-1-hüllglykoproteintrimere
EP3069730A3 (de) 2015-03-20 2017-03-15 International Aids Vaccine Initiative Lösliche hiv-1-hüllglykoproteintrimere
EP3072901A1 (de) 2015-03-23 2016-09-28 International Aids Vaccine Initiative Lösliche hiv-1-hüllglykoproteintrimere

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5219990A (en) * 1991-01-28 1993-06-15 Biogen, Inc. Papillomavirus e2 trans-activation repressors
WO1994015634A1 (en) * 1992-12-30 1994-07-21 Matthias Rath Tat and rev oligopeptides in hiv treatment
CA2215483C (fr) * 1995-03-08 2012-01-03 Jean-Francois Zagury Immunogenes denues de toxicite derivant d'une proteine de regulation retrovirale, anticorps, procede de preparation et compositions pharmaceutiques les renfermant
US5891994A (en) * 1997-07-11 1999-04-06 Thymon L.L.C. Methods and compositions for impairing multiplication of HIV-1
IT1297090B1 (it) * 1997-12-01 1999-08-03 Barbara Ensoli Tat di hiv-1 o suoi derivati, da soli od in combinazione, a scopo vaccinale, profilattico e terapeutico, contro l'aids i tumori e le
FR2773156B1 (fr) * 1997-12-26 2000-03-31 Biovacs Inc Nouveaux immunogenes anti-retroviraux (toxoides), nouveaux procedes de preparation et application a la prevention et au traitement du sida
NO311807B1 (no) 1999-03-04 2002-01-28 Bionor Immuno As HIV-peptider, antigener, vaksinepreparater, immunoassay- testsett og en metode for påvisning av antistoffer fremkalt av HIV
AU4082300A (en) * 1999-06-21 2001-01-09 Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The Hiv tat peptides and multiple peptide conjugate system
SE0001351L (sv) * 2000-04-12 2001-03-26 Kjell Sjoegren Smådjurstoalett

Also Published As

Publication number Publication date
JP2004508382A (ja) 2004-03-18
ES2296793T3 (es) 2008-05-01
DE60131432T2 (de) 2008-09-18
HUP0303132A3 (en) 2012-09-28
NZ524557A (en) 2005-04-29
CN101628933A (zh) 2010-01-20
HUP0303132A2 (hu) 2005-03-29
EP1322666A2 (de) 2003-07-02
AU2001286336B2 (en) 2007-03-15
CA2421199A1 (en) 2002-03-14
EA200300335A1 (ru) 2003-08-28
NO20004412D0 (no) 2000-09-04
SK287913B6 (sk) 2012-03-02
SK4012003A3 (en) 2003-09-11
BR0114046A (pt) 2003-07-22
CN1458936A (zh) 2003-11-26
ZA200301742B (en) 2004-06-21
NO20004412L (no) 2002-03-05
EP1322666B1 (de) 2007-11-14
NZ535908A (en) 2006-03-31
EA006210B1 (ru) 2005-10-27
WO2002020555A2 (en) 2002-03-14
US20050053616A1 (en) 2005-03-10
DE60131432D1 (de) 2007-12-27
NO314587B1 (no) 2003-04-14
AU8633601A (en) 2002-03-22
WO2002020555A3 (en) 2002-06-06
US7097971B2 (en) 2006-08-29
AR033997A1 (es) 2004-01-21

Similar Documents

Publication Publication Date Title
ATE406380T1 (de) Hiv-peptide aus konservierten regionen in gag p17 und deren anwendung z.b. in impfstoffen
ATE378350T1 (de) Hiv-peptide aus tat-, rev- und wef-konservierten regionen und deren anwendung z.b. als impfstoffkomponenten
IT249542Y1 (it) Struttura ripiegabile, quale una struttura espositiva.
DE60117859D1 (de) HARNSTOFFSUBSTITUIERTE IMIDAZOCHINOLINETHER und Arzneimittel, die diese umfassen.
RU2001129709A (ru) Макроциклические пептиды, обладающие активностью в отношении вируса гепатита C
ZA200407868B (en) 17alpha-Alkyl-17beta-oxy-estratrienes, uses thereof and pharmaceutical preparations.
ITTO20000779A0 (it) Composizioni farmaceutiche.
BR0207025B1 (pt) derivado de isoxazolina e herbicida contendo o mesmo como o ingrediente ativo.
BR0114985B1 (pt) recipiente dobrável.
ITTO20010005A0 (it) Formulazione farmaceutica.
ATE353909T1 (de) 3-stickstoff-6,7-dioxygenierte steroid verbindungen und verwendungen davon
BR0115810B1 (pt) composições cosméticas, dermatológicas e farmacêuticas isentas de tensoativos.
PT1328154E (pt) Composicao pesticida
MXPA02007478A (es) Vacuna contra el virus de inmunodeficiencia humana.
ATE323095T1 (de) 3,7-diazabicycloc3.3.1)-formulierungen als antiarrhythmika
DE60120888D1 (de) Saure, Öl-in-Wasser emulgierte Zusammensetzung
ATE269639T1 (de) Pestizide zusammensetzung
DE60213084D1 (de) 3,7-DIAZABICYCLOc3.3.1Ü-FORMULIERUNGEN ALS ANTIARRHYTHMIKA
TR200100257A3 (tr) Pamuk alisveris forumu.
MXPA03001857A (es) Composicones medicinales.
IT1317827B1 (it) Composizioni solventi.
Pandey Acharya Shukla: Pratinidhi nibandha
Fox Ancient Two-Legged Lizard Intrigues Scientists
IT1317895B1 (it) Pseudo-metalloproteine, loro preparazione e loro uso.
ES1047450Y (es) Sombrilla parasol plegable con proteccion lateral.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties